LETROZOLE CIPLA letrozole 2.5mg film-coated tablet blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

letrozole, Quantity: 2.5 mg

Pieejams no:

Cipla Australia Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Letrozole

Zāļu forma:

Tablet, film coated

Kompozīcija:

Excipient Ingredients: lactose monohydrate; sodium starch glycollate; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 400

Ievadīšanas:

Oral

Vienības iepakojumā:

30, 10

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

For the treatment of postmenopausal women with hormone receptor positive breast cancer (see Clinical Trials). The safety and efficacy of neoadjuvant use of letrozole has not been established. Letrozole is not indicated in hormone receptor negative disease.

Produktu pārskats:

Visual Identification: Yellow circular, biconvex, film coated tablet debossed with LT on one side and 2.5 on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2016-06-01